PCR System Leasing for Labs
Lease the PCR system that fits your workflow. Amplify DNA or RNA with precision—without tying up your budget.
What Is PCR?
Polymerase chain reaction (PCR) is a technique used to amplify small amounts of DNA or RNA, enabling detection and analysis for research, diagnostics, and clinical applications. PCR is foundational to molecular biology, infectious disease testing, and genetic analysis. The technique supports workflows ranging from gene expression studies to pathogen detection and mutation screening.
Why Lease a PCR System?
Whether you’re running traditional PCR, quantitative PCR (qPCR), or digital PCR (dPCR), high-quality thermal cyclers are essential to your workflow. But the cost of acquiring scalable, programmable, or high-throughput PCR systems—especially with real-time fluorescence detection—can be a barrier.
Leasing enables your lab to access the exact systems you need without large upfront investment. It’s ideal for research institutions, molecular diagnostics labs, and biotech companies that need precision, scalability, and speed—without locking up capital. As sample volume or detection requirements grow, leasing also allows you to upgrade without disruption.
Where Leasing a PCR System Adds Value
PCR technology—whether qPCR, digital PCR, or multiplex systems—is fundamental to diagnostics, molecular biology, and clinical research.
However, acquiring advanced PCR instruments with high-speed cycling, multiplex capabilities, or digital precision often requires significant upfront investment. Leasing is especially helpful when:
- You're scaling qPCR testing or clinical assay throughput — Get high-speed cyclers without capital delays.
- You need access to digital PCR or multiplex detection — Lease advanced platforms tailored to evolving assay needs.
- You want flexibility to adapt as workflows or funding change — Upgrade or adjust as your pipeline grows.
Whether you're expanding diagnostics or streamlining R&D workflows, leasing helps you stay efficient and budget-conscious.
Why Teams Lease with Excedr
Founder-friendly, non-dilutive capital
Ideal for early-stage or venture-backed teams—and a smart option for any lab looking to preserve equity while scaling.
Flexibility on equipment choice
No inventory limitations. You choose the system that fits your workflow—we handle the financing.
Lease terms aligned with your growth
2–5 year terms that support your budget, equipment lifecycle, and scaling timeline.
Quick approvals, flexible terms
Get approved in days—not weeks—with no collateral, IP pledges, or debt covenants required.
White-glove service & procurement
Equipment sourcing, vendor coordination, and lease logistics are streamlined to reduce your team’s internal workload.
Reliable support when it matters
Our vendor relationships help resolve issues quickly—so you stay productive and hit key milestones.
Leasing Solutions We Provide
Operating Leases
Treat lease payments as operating expenses, not debt. This simplifies accounting and preserves flexibility.
Sale Lease-Backs
Convert owned equipment into working capital. Keep it off your balance sheet and treat payments as operating expenses.
Popular PCR System Manufacturers
Straightforward Application Process
Tell Us What You Need
Already have a quote or PO? Just let us know the equipment you want to lease—we’ll take it from there.
Get Approved Quickly
Our in-house underwriting team reviews your financials fast—no outsourcing, no red tape—so you get a decision in days, not weeks.
We Handle the Rest
We handle the logistics and coordinate with the vendor so you can get to work—no upfront capital required.
Helping Scientists Scale & Succeed
"We used Excedr when it was time for us to make a large capital equipment purchase and the whole leasing process was smooth, quick, and seamless.
As a busy start-up CEO, I am always aware of how important it is to keep our science progressing while on a tight budget.
Working with Excedr made it possible for us to accelerate our scientific discovery pipeline without a large outlay of capital."
Jessica Grossman
CEO, IgGenix
"Building a biotech is a lot of work. Excedr has been a dynamite partner in making that scaling happen.
They were a great partner when scaling Distributed Bio from an 8 member lab team to 35 members by the time of acquisition. When I started Centivax, Jon was one of the first people I called.
I recommend them for any biotech startup."
Jacob Glanville
CEO & President, Centivax
"Securing top-tier lab equipment while managing cash flow is a constant challenge. Excedr has been an invaluable partner in helping KiraGen Bio access the high-quality instrumentation we need without the heavy upfront costs.
Their flexible leasing options and outstanding support allow us to focus on advancing our research rather than worrying about equipment procurement and maintenance. For any biotech startup looking to scale efficiently, I can’t recommend Excedr enough."
Aaron Edwards
Co-Founder & CEO, KiraGen Bio
"Excedr helped us to finance a BLI system about a year ago. Sylvia did an excellent job at helping us to understand our options, since our company was new to equipment financing.
The leasing process was fast and easy when compared with self-funding our purchase, plus the speed and ease with which Excedr onboarded us freed up our team’s time to focus on research and grant management.
Max Brennan
General Counsel & VP Operations, Zab Bio
“The lease of our Zeiss EVO10 electron microscope has significantly impacted our outside analysis costs, realizing a significant savings in the 1st year.
Having the instrument on-site has greatly improved our response times to field issues and fabrication challenges, while improving our Engineering and Production Teams' overall understanding of our product lines."
Tom Raber
Principal Mechanical Technician, Plug Power
Frequently Asked Questions
Lease Your Next PCR System & Accelerate R&D
Don’t let capital constraints limit your lab’s amplification capabilities. Our leasing program is designed to remove friction from equipment procurement so you can stay focused on producing accurate, reliable results.